Literature DB >> 30760531

Multilocus Variable-Number Tandem-Repeat Analysis of Clostridioides difficile Clusters in Ribotype 027 Isolates and Lack of Association with Clinical Outcomes.

Julian R Garneau1, Claire Nour Abou Chakra1, Louis-Charles Fortier1, Annie-Claude Labbé2, Andrew E Simor3, Wayne Gold4, Matthew Muller5, Allison McGeer6, Jeff Powis7, Kevin Katz8, Jacques Pépin1, Louis Valiquette9.   

Abstract

The epidemiology of Clostridioides difficile infection (CDI) has drastically changed since the emergence of the epidemic strain BI/NAP1/027, also known as ribotype 027 (R027). However, the relationship between the infecting C. difficile strain and clinical outcomes is still debated. We hypothesized that certain subpopulations of R027 isolates could be associated with unfavorable outcomes. We applied high-resolution multilocus variable-number tandem-repeat analysis (MLVA) to characterize C. difficile R027 isolates collected from confirmed CDI patients recruited across 10 Canadian hospitals from 2005 to 2008. PCR ribotyping was performed first to select R027 isolates that were then analyzed by MLVA (n = 450). Complicated CDI (cCDI) was defined by the occurrence of any of admission to an intensive care unit, colonic perforation, toxic megacolon, colectomy, and if CDI was the cause or contributed to death within 30 days after enrollment. Three major MLVA clusters were identified, MC-1, MC-3, and MC-10. MC-1 and MC-3 were exclusive to Quebec centers, while MC-10 was found only in Ontario. Fewer cases infected with MC-1 developed cCDI (4%) than those infected with MC-3 and MC-10 (15% and 16%, respectively), but a statistically significant difference was not reached. Our data did not identify a clear association between subpopulations of R027 and different clinical outcomes; however, the data confirmed the utility of MLVA's higher discrimination potential to better characterize CDI populations in an epidemiological analysis. For a patient with CDI, the progression toward an unfavorable outcome is a complex process that probably includes several interrelated strain and host characteristics.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Clostridioides difficilezzm321990; Clostridium difficilezzm321990; MLVA typing; complication; hypervirulent; ribotype 027

Year:  2019        PMID: 30760531      PMCID: PMC6497997          DOI: 10.1128/JCM.01724-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  Locus-specific mutational events in a multilocus variable-number tandem repeat analysis of Escherichia coli O157:H7.

Authors:  Anna C Noller; M Catherine McEllistrem; Kathleen A Shutt; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

3.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors:  Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.

Authors:  Thomas Akerlund; Ingela Persson; Magnus Unemo; Torbjörn Norén; Bo Svenungsson; Marlene Wullt; Lars G Burman
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

5.  A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.

Authors:  Bruno Hubert; Vivian G Loo; Anne-Marie Bourgault; Louise Poirier; André Dascal; Elise Fortin; Marc Dionne; Manon Lorange
Journal:  Clin Infect Dis       Date:  2006-12-06       Impact factor: 9.079

6.  Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals.

Authors:  Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; A William Pasculle; Stuart Johnson; Dale N Gerding; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

7.  Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis.

Authors:  Renate J van den Berg; Inge Schaap; Kate E Templeton; Corné H W Klaassen; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

8.  Emergence of reduced susceptibility to metronidazole in Clostridium difficile.

Authors:  Simon D Baines; Rachael O'Connor; Jane Freeman; Warren N Fawley; Celine Harmanus; Paola Mastrantonio; Ed J Kuijper; Mark H Wilcox
Journal:  J Antimicrob Chemother       Date:  2008-08-07       Impact factor: 5.790

9.  Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains.

Authors:  W N Fawley; J Freeman; C Smith; C Harmanus; R J van den Berg; E J Kuijper; M H Wilcox
Journal:  J Clin Microbiol       Date:  2008-01-23       Impact factor: 5.948

10.  Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.

Authors:  George Killgore; Angela Thompson; Stuart Johnson; Jon Brazier; Ed Kuijper; Jacques Pepin; Eric H Frost; Paul Savelkoul; Brad Nicholson; Renate J van den Berg; Haru Kato; Susan P Sambol; Walter Zukowski; Christopher Woods; Brandi Limbago; Dale N Gerding; L Clifford McDonald
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

View more
  2 in total

1.  To Lump or To Split: Does Strain Lineage for Clostridioides difficile Matter?

Authors:  Scott R Curry
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

2.  External validation of clinical prediction rules for complications and mortality following Clostridioides difficile infection.

Authors:  Catherine Beauregard-Paultre; Claire Nour Abou Chakra; Allison McGeer; Annie-Claude Labbé; Andrew E Simor; Wayne Gold; Matthew P Muller; Jeff Powis; Kevin Katz; Suzanne M Cadarette; Jacques Pépin; Louis Valiquette
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.